Skip to main content
OpenTrials
Completed

NCT Number: NCT06361862

Does Continuous Vital Sign Monitoring Increase Investigations and Interventions in Complication-free Patients?

This aim of this study is to investigate whether active alerts during CVSM result in an increased number of diagnostic tests and treatments in complication free patients, hypothesizing that more interventions are performed in the CVSM-group than standard of care (EWS) group.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cancer Chronic Disease Chronic Obstructive Pulmonary Disease Disease Attributes Lung Diseases Lung Diseases, Obstructive Neoplasms Pathologic Processes Pathological Conditions, Signs and Symptoms Pulmonary Disease, Chronic Obstructive Respiratory Tract Diseases Surgery-Complications

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Eske Kvanner Aasvang

Copenhagen, 2100, Denmark

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • • Patients from WARD - RCT.

Exclusion criteria

-

Treatment and study plan

Active alarms from WARD software

Device

Wireless continuous vital sign monitoring with real time staff alerts

Primary outcomes

  1. Frequency of patients having at least one of the following tests/treatments:

    Time frame: 72 hours

    • CT-scans
    • MRi-Scans
    • PET-Scans
    • X-ray (ordered by attending doctor, besides standard procedural investigations)
    • ultrasounds
    • Antibiotics (ordered by attending doctor, besides standard procedural treatment)
    • Arterial puncture
    • Gastro- colonoscopy
    • Dialysis
    • Central venous line (incl. dialysis catheter)

Secondary outcomes

  1. The frequency of individual treatments and diagnostics:

    Time frame: 72 hours

    Treatments:

    • Antibiotics (ordered by attending doctor, besides standard procedural treatment)
    • CPAP
    • blood-transfusion
    • IV-fluids
    • Dialysis
    • Naso-gastric tube (ordered by attending doctor, besides standard procedural treatment)
    • Central venous line (incl. dialysis catheter)

    Diagnostics:

    • Imaging CT, X-ray, MRI, PET, and ultrasound.
    • Blood tests: arterial blood gases, cultures, and other blood sample tests.
    • ECG
    • cultures from urine, sputum, swabs, and feces.

Sponsors and collaborators

Lead sponsor

Rigshospitalet, Denmark

Other

Collaborators

  • Bispebjerg Hospital

Registry information

Official study title

Does Continuous Vital Sign Monitoring Increase Investigations and Interventions in Complication-free Patients? - a Sub-study of Randomized Clinical Trials

Acronym: WARD-OT

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Apr 12, 2024
Registry last updated
Apr 6, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.